// App-Quantinova.ai

OP0220 (2021) : SECULAR TRENDS IN BASELINE CHARACTERISTICS, TREATMENT RETENTION AND RESPONSE RATES IN 17453 BIONAÏVE PSORIATIC ARTHRITIS PATIENTS INITIATING TNFI – RESULTS FROM THE EUROSPA COLLABORATION

Researchers

Presenter

  • S. N. Christiansen

Principal Investigators

  • S. H. Rasmussen

  • A. G. Loft

  • J. K. Wallman

  • F. Iannone

  • B. Michelsen

  • M. J. Nissen

  • J. Zavada

  • M. J. Santos

  • M. Pombo-Suarez

  • K. Eklund

  • M. Tomsic

  • B. Gudbjornsson

  • I. Sari

  • C. Codreanu

  • D. DI Giuseppe

  • B. Glintborg

  • M. Sebastiani

  • K. M. Fagerli

  • B. Moeller

  • K. Pavelka

  • A. Barcelos

  • C. Snchez-Piedra

  • H. Relas

  • Z. Rotar

  • T. Love

  • S. Akar

  • R. Ionescu

  • G. Macfarlane

  • M. G. H. Van de Sande

  • M. L. Hetland

  • M. stergaard

Medical Centers

  • Rigshospitalet Glostrup, Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopedics, Glostrup, Denmark

  • Aarhus university Hospital, Department of Urology, Skejby, Denmark

  • Rigshospitalet, Glostrup, The DANBIO Registry, Glostrup, Denmark

  • Lund University Hospital and Lund University, Lund, Sweden

  • University of Pisa, Gastroenterology Unit, Pisa, Italy

  • Diakonhjemmet Hospital, Division of Rheumatology and Research, Norway, Norway

  • Institute of Rheumatology, Prague, Czech Republic

  • Hospital Garcia de Orta, Rheumatology Department, Lisbon, Portugal

  • Hospital Clinico Universitario, Rheumatology Service, Santiago de Compostela, Spain

  • Helsinki University Central Hospital, Division of Gastroenterology, Helsinki, Finland

  • University Medical Centre Ljubljana, Department of Rheumatology, and Universitiy of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia

  • Centre for Rheumatology Research, Landspitali and Faculty of Medicine, University of Iceland, Reykjavik, Iceland

  • Dokuz Eylul University School of Medicine, Division of Rheumatology, İzmir, Turkey

  • University of Medicine and Pharmacy Carol Davila, Bucharest, Romania

  • Karolinska Institutet. Department of Medicine. Stockholm, Sweden, Stockholm, Sweden

  • Inselspital, University Hospital of Bern, Rheumatology, Immunology and Allergy, Bern, Switzerland

  • Centro Hospitalar do Baixo Vouga, Departamento de Pneumologia, Aveiro, Portugal

  • Sociedad Española de Reumatologia, Research Unit, Madrid, Spain

  • Dokuz Eylul University School of Medicine, Division of Rheumatology, İzmir, Turkey

  • University of Aberdeen, Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), School of Medicine, Medical Sciences and Nutrition, Aberdeen, United Kingdom

  • Amsterdam Rheumatology and Immunology Center, VU University Medical center, Amsterdam, Netherlands

Locations

  • Denmark

  • Sweden

  • Italy

  • Norway

  • Switzerland

  • Czech Republic

  • Portugal

  • Spain

  • Finland

  • Slovenia

  • Iceland

  • Turkey

  • Romania

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Dermatology

Disease

  • Psoriatic arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Novartis

Result

  • N/A